INVO Fertility Inc. (IVF)
INVO Fertility Inc. (IVF) Stock Price, Analysis & Data
| Bid | 0.73 |
| Market Cap | 1.84M |
| Revenue (ttm) | 7.22M |
| Net Income (ttm) | -11.19M |
| Beta | n/a |
| EPS (ttm) | 248.92 |
| PE Ratio (ttm) | 0 |
| Forward PE | -0.13 |
| P/B (ttm) | 0.12 |
| P/S (ttm) | 0.25 |
| Earnings Date | n/a |
| Ask | 1.3 |
| Volume | 14,788 |
| Avg. Volume (20D) | 2,412,832 |
| Open | 1.01 |
| Previous Close | 1.03 |
| Day's Range | 1.00 - 1.04 |
| 52-Week Range | 0.90 - 84.40 |
| Analyst | n/a |
| Price Target | 20 (1841.75%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IVF
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The ...
Financial Performance
In 2025, INVO Fertility's revenue was 6.84M, an increase of 4.73% compared to the previous year's 6.53M. Earnings were -23.32M, an increase of 151.9%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for IVF stock is "null". The 12-month stock price forecast is 20, which is upside of 1841.75% from the latest price.
Stock Forecasts
